122 related articles for article (PubMed ID: 37150886)
1. (+)-Catechin Attenuates Multiple Atherosclerosis-Associated Processes In Vitro, Modulates Disease-Associated Risk Factors in C57BL/6J Mice and Reduces Atherogenesis in LDL Receptor Deficient Mice by Inhibiting Inflammation and Increasing Markers of Plaque Stability.
Chan YH; Moss JWE; Williams JO; Ferekidis N; Alshehri N; Hughes TR; Menendez-Gonzalez JB; Plummer SF; Michael DR; Rodrigues NP; Ramji DP
Mol Nutr Food Res; 2023 Jul; 67(14):e2200716. PubMed ID: 37150886
[TBL] [Abstract][Full Text] [Related]
2. The Lab4P Consortium of Probiotics Attenuates Atherosclerosis in LDL Receptor Deficient Mice Fed a High Fat Diet and Causes Plaque Stabilization by Inhibiting Inflammation and Several Pro-Atherogenic Processes.
O'Morain VL; Chan YH; Williams JO; Alotibi R; Alahmadi A; Rodrigues NP; Plummer SF; Hughes TR; Michael DR; Ramji DP
Mol Nutr Food Res; 2021 Sep; 65(17):e2100214. PubMed ID: 34216185
[TBL] [Abstract][Full Text] [Related]
3. Pro-atherogenic actions of signal transducer and activator of transcription 1 serine 727 phosphorylation in LDL receptor deficient mice via modulation of plaque inflammation.
Al-Ahmadi W; Webberley TS; Joseph A; Harris F; Chan YH; Alotibi R; Williams JO; Alahmadi A; Decker T; Hughes TR; Ramji DP
FASEB J; 2021 Oct; 35(10):e21892. PubMed ID: 34569651
[TBL] [Abstract][Full Text] [Related]
4. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
[TBL] [Abstract][Full Text] [Related]
5. Dihomo-γ-linolenic acid inhibits several key cellular processes associated with atherosclerosis.
Gallagher H; Williams JO; Ferekidis N; Ismail A; Chan YH; Michael DR; Guschina IA; Tyrrell VJ; O'Donnell VB; Harwood JL; Khozin-Goldberg I; Boussiba S; Ramji DP
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2538-2550. PubMed ID: 31202985
[TBL] [Abstract][Full Text] [Related]
6. Molecular hydrogen stabilizes atherosclerotic plaque in low-density lipoprotein receptor-knockout mice.
Song G; Zong C; Zhang Z; Yu Y; Yao S; Jiao P; Tian H; Zhai L; Zhao H; Tian S; Zhang X; Wu Y; Sun X; Qin S
Free Radic Biol Med; 2015 Oct; 87():58-68. PubMed ID: 26117323
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of experimental atherosclerosis by interleukin-19.
Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
9. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
10. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in
Ray M; Gabunia K; Vrakas CN; Herman AB; Kako F; Kelemen SE; Grisanti LA; Autieri MV
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1297-1308. PubMed ID: 29674474
[TBL] [Abstract][Full Text] [Related]
11. Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes.
Stöger JL; Boshuizen MC; Brufau G; Gijbels MJ; Wolfs IM; van der Velden S; Pöttgens CC; Vergouwe MN; Wijnands E; Beckers L; Goossens P; Kerksiek A; Havinga R; Müller W; Lütjohann D; Groen AK; de Winther MP
Thromb Haemost; 2016 Aug; 116(3):565-77. PubMed ID: 27358035
[TBL] [Abstract][Full Text] [Related]
12. Vinexin β Ablation Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice by Inactivating the Akt-Nuclear Factor κB Inflammatory Axis.
Guan H; Cheng WL; Guo J; Chao ML; Zhang Y; Gong J; Zhu XY; She ZG; Huang Z; Li H
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28209562
[TBL] [Abstract][Full Text] [Related]
13. Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosis.
van der Vorst EP; Jeurissen M; Wolfs IM; Keijbeck A; Theodorou K; Wijnands E; Schurgers L; Weber S; Gijbels MJ; Hamers AA; Dreymueller D; Rose-John S; de Winther MP; Ludwig A; Saftig P; Biessen EA; Donners MM
Am J Pathol; 2015 Apr; 185(4):1145-55. PubMed ID: 25659879
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
[TBL] [Abstract][Full Text] [Related]
15. Infusion of lin-/sca-1+ and endothelial progenitor cells improves proinflammatory and oxidative stress markers in atherosclerotic mice.
Tousoulis D; Briasoulis A; Vogiatzi G; Valatsou A; Kourkouti P; Pantopoulou A; Papageorgiou N; Perrea D; Stefanadis C
Int J Cardiol; 2013 Sep; 167(5):1900-5. PubMed ID: 22622053
[TBL] [Abstract][Full Text] [Related]
16. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
17. CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation.
Chang TT; Yang HY; Chen C; Chen JW
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911750
[TBL] [Abstract][Full Text] [Related]
18. P2X
Peikert A; König S; Suchanek D; Rofa K; Schäfer I; Dimanski D; Karnbrock L; Bulatova K; Engelmann J; Hoppe N; Wadle C; Heidt T; Albrecht P; von Garlen S; Härdtner C; Hilgendorf I; Wolf D; von Zur Mühlen C; Bode C; Zirlik A; Duerschmied D; Merz J; Stachon P
Sci Rep; 2022 Feb; 12(1):2801. PubMed ID: 35181718
[TBL] [Abstract][Full Text] [Related]
19. RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis.
Cui XB; Luan JN; Dong K; Chen S; Wang Y; Watford WT; Chen SY
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):e36-e47. PubMed ID: 29449334
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages.
Zhang X; Li J; Qin JJ; Cheng WL; Zhu X; Gong FH; She Z; Huang Z; Xia H; Li H
J Lipid Res; 2017 May; 58(5):895-906. PubMed ID: 28258089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
